-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
ADC Therapeutics SA quarterly/annual Revenues history and growth rate from Q1 2023 to Q2 2024.
- ADC Therapeutics SA Revenues for the quarter ending June 30, 2024 was $17.4M, a 9.71% decline year-over-year.
- ADC Therapeutics SA annual Revenues for 2023 was $69.6M, a 66.9% decline from 2022.